دورية أكاديمية
ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results
| العنوان: | ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results |
|---|---|
| المؤلفون: | Koh, Youngil, Ghobrial, Irene, Martinez-Lopez, Joaquin, Rodriguez-Otero, Paula, Lepine, Lucie, Mace, Sandrine, Oprea, Corina, Mateos, Maria-Victoria, Devisme, Christine, Dubin, Franck, Schjesvold, Fredrik, Peceliunas, Valdas, Leleu, Xavier, Kim, Jin Seok, Besisik, Sevgi Kalayoglu, Hungria, Vania, Hermansen, Emil, de la Rubia, Javier, Quach, Hang, Prince, Miles, Parmar, Gurdeep |
| المساهمون: | Harvard University ,, 2770412 |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Onkoloji, Sağlık Bilimleri, Tıp, HEMATOLOJİ, Klinik Tıp (MED), Klinik Tıp, ONKOLOJİ, Health Sciences, Hematology, Oncology, Hematoloji, İç Hastalıkları, Dahili Tıp Bilimleri |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 2152-2650 |
| العلاقة: | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA; Ghobrial I., Rodriguez-Otero P., Koh Y., Martinez-Lopez J., Parmar G., Prince M., Quach H., de la Rubia J., Hermansen E., Hungria V., et al., "ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results", CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, 2021; vv_1032021; av_be09d9a7-e1ea-476f-8197-884cf8344e0e; http://hdl.handle.net/20.500.12627/173933Test; 21 |
| الإتاحة: | https://doi.org/20.500.12627/173933Test https://hdl.handle.net/20.500.12627/173933Test |
| رقم الانضمام: | edsbas.41D0E08A |
| قاعدة البيانات: | BASE |
| تدمد: | 21522650 |
|---|